SCHEMBL28841914

SCHEMBL28841914

NC(=O)C1(c2cc(N)ncn2)CC1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.32
▸ CHKA P35790 1/20 0.32
▸ GABRP O00591 2/20 0.31
▸ GABRD O14764 2/20 0.31
▸ GABRA1 P14867 2/20 0.31
▸ GABRB1 P18505 2/20 0.31
▸ GABRG2 P18507 2/20 0.31
▸ GABRB3 P28472 2/20 0.31
▸ GABRA5 P31644 2/20 0.31
▸ GABRA3 P34903 2/20 0.31
▸ GABRA2 P47869 2/20 0.31
▸ GABRB2 P47870 2/20 0.31
▸ GABRA4 P48169 2/20 0.31
▸ GABRE P78334 2/20 0.31
▸ GABRA6 Q16445 2/20 0.31
▸ GABRG1 Q8N1C3 2/20 0.31
▸ GABRG3 Q99928 2/20 0.31
▸ GABRQ Q9UN88 2/20 0.31
▸ ASIC3 Q9UHC3 1/20 0.31
▸ MET P08581 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30161959 1.00 CA2 (0.32) CA2CHKAGABRPGABRDGABRA1
SCHEMBL29974159 0.81 BRAF (0.32) —
SCHEMBL31205355 0.73 MKNK1 (0.42) CYP11B2MKNK1MKNK2
SCHEMBL30435922 0.71 P2RX7 (0.40) LMNACYP11B2MKNK1
SCHEMBL19814417 0.71 P2RX7 (0.40) LMNACYP11B2MKNK1
SCHEMBL28841931 0.70 — —
SCHEMBL30907651 0.70 OPRL1 (0.36) CYP11B2
SCHEMBL12002704 0.69 MAP4K4 (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12002836 0.69 SYK (0.34) LMNA
SCHEMBL29284164 0.69 KDM4E (0.43) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3521289-B1 MNK INHIBITORS AND METHODS RELATED THERETO EFFECTOR THERAPEUTICS INC (US) 2023-10-25 — — EP disclosed
CN-110183449-B Mnk inhibitors and methods related thereto 效应治疗股份有限公司 2022-08-19 — — CN disclosed
Send feedback